Guardant Health (GH) Interest & Investment Income (2017 - 2026)

Guardant Health has reported Interest & Investment Income for 10 years, with the latest figure at $10.2 million in Q2 2026.

• Quarterly Interest & Investment Income rose 34.91% year-over-year to $10.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $38.8 million (down 6.76% YoY) and the FY2025 annual result came in at $34.1 million, down 36.5% from the prior year.
• Interest & Investment Income fell to $10.2 million in Q2 2026 per GH's latest filing, from $11.2 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $14.9 million in Q1 2024 and troughed at $778000.0 in Q1 2022.
• A 5-year average of $8.4 million and a median of $9.6 million in 2025 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2022 and 2023: Interest & Investment Income sank 49.84% in 2022, then surged 566.48% in 2023.
• Over 5 years, Interest & Investment Income stood at $2.2 million in 2022, then surged by 545.95% to $13.9 million in 2023, then retreated by 16.09% to $11.7 million in 2024, then declined by 13.91% to $10.0 million in 2025, then rose by 1.66% to $10.2 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $10.2 million, $11.2 million, and $10.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.